ADAM9 coordinates genes in anoikis resistance for lung cancer metastases

被引：0
|
作者：
Sher, Y. [1 ]
Lin, C. [2 ]
Huang, C. [3 ]
Lai, L. [4 ]
Kuo, T. [3 ]
Tseng, G. [5 ]
Hung, M. [6 ]
机构：
[1] China Med Univ, Taichung, Taiwan
[2] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan
[3] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan
[4] Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan
[5] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan
[6] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)50150-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
177
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [41] ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis
    Chiu, Kuo-Liang
    Lin, Yu-Sen
    Kuo, Ting-Ting
    Lo, Chia-Chien
    Huang, Yu-Kai
    Chang, Hsien-Fang
    Chuang, Eric Y.
    Lin, Ching-Chan
    Cheng, Wei-Chung
    Liu, Yen-Nien
    Lai, Liang-Chuan
    Sher, Yuh-Pyng
    ONCOTARGET, 2017, 8 (29) : 47365 - 47378
  • [42] ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
    R Grützmann
    J Lüttges
    B Sipos
    O Ammerpohl
    F Dobrowolski
    I Alldinger
    S Kersting
    D Ockert
    R Koch
    H Kalthoff
    H K Schackert
    H D Saeger
    G Klöppel
    C Pilarsky
    British Journal of Cancer, 2004, 90 : 1053 - 1058
  • [43] miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer
    Fu, Qiang
    Cheng, Jing
    Zhang, Jindai
    Zhang, Yonglei
    Chen, Xiaobing
    Luo, Suxia
    Xie, Jianguo
    ONCOLOGY REPORTS, 2017, 37 (01) : 123 - 130
  • [44] A pan-cancer study of ADAM9's immunological function and prognostic value particularly in liver cancer
    Amelimojarad, Mandana
    Amelimojarad, Melika
    Wang, Jiang
    Tavakolpour, Vahid
    Shariati, Parvin
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [45] ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
    Grützmann, R
    Lüttges, J
    Sipos, B
    Ammerpohl, O
    Dobrowolski, F
    Alldinger, I
    Kersting, S
    Ockert, D
    Koch, R
    Kalthoff, H
    Schackerts, HK
    Saeger, HD
    Klöppel, G
    Pilarsky, C
    BRITISH JOURNAL OF CANCER, 2004, 90 (05) : 1053 - 1058
  • [46] ADAM9 and EGFR Correlated With Lymph Node Metastasis Predicts Worse Prognosis in Surgically Resected Non-Small Cell Lung Cancer
    Zhang, Jun
    Chen, Ning
    Qi, Juan
    Zhou, Baosen
    Qiu, Xueshan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S729 - S729
  • [47] MiR-126 Acts as a Tumor Suppressor in Pancreatic Cancer Cells via the Regulation of ADAM9
    Hamada, Shin
    Satoh, Kennichi
    Fujibuchi, Wataru
    Hirota, Morihisa
    Kanno, Atsushi
    Unno, Jun
    Masamune, Atsushi
    Kikuta, Kazuhiro
    Kume, Kiyoshi
    Shimosegawa, Tooru
    MOLECULAR CANCER RESEARCH, 2012, 10 (01) : 3 - 10
  • [48] HIGHLY EXPRESSED ADAM9 IN COMPLETELY RESECTED STAGE I NON-SMALL CELL LUNG CANCER CASES PREDICTS A SHORTENED SURVIVAL
    Zhang, Jun
    Qi, Juan
    Chen, Ning
    Guo, Yi
    Fu, Weineng
    Zhou, Baosen
    He, Anguang
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1068 - S1069
  • [49] Aspirin suppresses breast cancer metastasis to lung by targeting anoikis resistance
    Xu, Ruijie
    Yan, Yongheng
    Zheng, Xu
    Zhang, Hao
    Chen, Wei
    Li, Haitao
    Dong, Zigang
    CARCINOGENESIS, 2022, 43 (02) : 104 - 114
  • [50] microRNA-1298 inhibits the malignant behaviors of breast cancer cells via targeting ADAM9
    Chen, Weili
    Lu, Qing
    Li, Siyu
    Zhang, Xinyue
    Xue, Xiaohong
    BIOSCIENCE REPORTS, 2020, 40
12345